In vitro studies using SRC kinase inhibitors reveal that SFKs play an active role in BCR-ABL signal transduction and have demonstrated that inhibition of SFKs results in growth arrest and induction of apoptosis in Ph+ CML cell lines [32]. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.